GNRX

VanEck Vectors Generic Drugs ETF

Up$22.33
+$0.39
(+1.78%)
As of 6:20:00 PM EDT | 2/12/19  |  Market Closed

GNRX Trading Data

Open

$22.32

Low Price

$22.29

High Price

$22.33

Previous Last Price

$21.93

Bid Size

$0 X 0

Ask Size

$0 X 0

GNRX Portfolio Data

AUM

$3,359,300

Shares

150

PE Ratio

24.27

Price / Book Ratio

2.84

Expense Ratio

0.57

Net Asset Value

$22.40

Volume

Volume

1,200

Avg. Volume (YDT)

1,960

Dollar Volume

$0

Weekly Avg. Volume

3,500

Monthly Avg. Volume

2,410

Quarterly Avg. Volume

1,777

GNRX Fund Description

The VanEck Vectors Generic Drugs ETF seeks to replicate as closely as possible, before fees and expenses, the price and yield performance of the Indxx Global Generics and New Pharma Index, which is intended to track the overall performance of companies that derive a significant proportion of their revenues or that have the potential to derive a significant proportion of their revenues from the generic drug industry, or that have a primary business focus on the generic drug industry. Expenses for GNRX are capped contractually at 0.55% until at least February 1, 2018. Cap excludes certain expenses, such as interest.

GNRX Chart

GNRX Summary

Fund Family

Van Eck Associates

Tracks This Index

VanEck Vectors Generic Drugs ETF

Inception Date

2016-01-12

Asset Class

Equity

Asset Class Size

International

GNRX Classification

Region (General)

Global

Region (Specific)

Sector

Equity Index

Leveraged Family

GNRX Holdings

Top 10 Holdings

Pfizer Inc (PFE)
8.83%
Iqvia Holdings Inc (IQV)
7.04%
Celltrion Inc (068270 KS)
6.59%
Lonza Group Ag (LONN SW)
6.58%
Teva Pharmaceutical Industries Ltd (TEVA)
6.5%
Mylan Nv (MYL)
5.13%
Sun Pharmaceutical Industries Ltd (SUNP IN)
4.68%
Cspc Pharmaceutical Group Ltd (1093 HK)
4.07%
Sino Biopharmaceutical Ltd (1177 HK)
3.52%
Kyowa Hakko Kirin Co Ltd (4151 JP)
3.3%

Total GNRX Holdings

Total Holdings: 41

Pfizer Inc (PFE)
8.83%
Iqvia Holdings Inc (IQV)
7.04%
Celltrion Inc (068270 KS)
6.59%
Lonza Group Ag (LONN SW)
6.58%
Teva Pharmaceutical Industries Ltd (TEVA)
6.5%
Mylan Nv (MYL)
5.13%
Sun Pharmaceutical Industries Ltd (SUNP IN)
4.68%
Cspc Pharmaceutical Group Ltd (1093 HK)
4.07%
Sino Biopharmaceutical Ltd (1177 HK)
3.52%
Kyowa Hakko Kirin Co Ltd (4151 JP)
3.3%
Albemarle Corp (ALB)
3.25%
Taisho Pharmaceutical Holdings Co Ltd (4581 JP)
2.71%
Perrigo Co Plc (PRGO)
2.53%
Icon Plc (ICLR)
2.14%
Pra Health Sciences Inc (PRAH)
1.9%
Aurobindo Pharma Ltd (ARBP IN)
1.86%
Charles River Laboratories Internationa (CRL)
1.83%
Sinopharm Group Co Ltd (1099 HK)
1.77%
Hisamitsu Pharmaceutical Co Inc (4530 JP)
1.73%
Cipla Ltd/India (CIPLA IN)
1.7%
Dr Reddy s Laboratories Ltd (RDY)
1.67%
Lupin Ltd (LPC IN)
1.57%
Hikma Pharmaceuticals Plc (HIK.LS)
1.56%
Alkermes Plc (ALKS)
1.54%
Biocon Ltd (BIOS IN)
1.53%
Cadila Healthcare Ltd (CDH IN)
1.5%
Syneos Health Inc (SYNH)
1.49%
Aspen Pharmacare Holdings Ltd (APN SJ)
1.45%
Kalbe Farma Tbk Pt (KLBF IJ)
1.42%
Hanmi Science Co Ltd (008930 KS)
1.18%
Torrent Pharmaceuticals Ltd (TRP IN)
1.15%
Taro Pharmaceutical Industries Ltd (TARO)
1.15%
Orion Oyj (ORNBV FH)
1.02%
Richter Gedeon Nyrt (RICHT HB)
1.02%
Endo International Plc (ENDP)
0.83%
Shanghai Pharmaceuticals Holding Co Ltd (2607 HK)
0.67%
Amneal Pharmaceuticals Inc (AMRX)
0.62%
Shanghai Fosun Pharmaceutical Group Co (2196 HK)
0.55%
Guangzhou Baiyunshan Pharmaceutical Hol (874 HK)
0.18%
Van Eck Vectors Generic Drugs ETF (GNRX)
0%
0%

GNRX Technicals

Alpha

0

Beta

1.16

Leverage

Long

Standard Deviation

1.25

GNRX Dividends

Dividend Date

2018-12-20

Latest Dividend

0.006

Annual Dividend

0.01

Annual Dividend Rate

0.01

Annual Dividend Yield

0.03

GNRX Performance

YTD Return

7.85%

1 Year Return

-9.14%

3 Year Return

-2.34%

5 Year Return

0%

10 Year Return

-8.58%

GNRX Related Articles